Research from UC Santa Cruz indicates that the P3 peptide—an alternative cleavage product of the amyloid precursor protein—may play a role in Alzheimer’s disease.

New UC Riverside-led research suggests Alzheimer’s arises not simply from plaques forming in the brain, as is widely believed, but from one protein interfering with the normal job of another ...

Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of tau by amyloid beta, rather than aggregation of either protein, may be the ...

A major new study finds people with type 1 diabetes face nearly three times the dementia risk. But lifestyle changes and new treatments offer real hope.

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Study highlights rising dementia concerns as type 1 diabetes patients live longer ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease.

Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they consumed relatively large amounts of meat.

A study in the journal Neurology has shown that people with type 1 diabetes are three times more likely to develop dementia ...

Alzheimer's disease (AD) is a neurodegenerative disease that causes progressive memory loss and a significant decline in ...